(19)
(11) EP 2 279 208 A1

(12)

(43) Date of publication:
02.02.2011 Bulletin 2011/05

(21) Application number: 09745745.1

(22) Date of filing: 13.05.2009
(51) International Patent Classification (IPC): 
C07K 16/24(2006.01)
A61P 37/08(2006.01)
A61P 11/06(2006.01)
(86) International application number:
PCT/EP2009/055745
(87) International publication number:
WO 2009/138413 (19.11.2009 Gazette 2009/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 15.05.2008 US 152903
11.12.2008 WO PCT/EP2008/067295
04.03.2009 US 397826

(71) Applicant: Domantis Limited
Brentford, Middlesex TW8 9GS (GB)

(72) Inventors:
  • DE SILVA, Inusha
    Cambridge Cambridgeshire CB4 0WG (GB)
  • DE WILDT, Rudolf, Maria
    Stevenage Hertfordshire SG2 1NY (GB)
  • DIMECH, Caroline, J
    Stevenage Hertfordshire SG1 2NY (GB)
  • PUPECKA, Malgorzata
    Cambridge Cambridgeshire CB4 0WG (GB)
  • SPARKS, Catherine, A
    Cambridge Cambridgeshire CB4 0WG (GB)

(74) Representative: Easeman, Richard Lewis 
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) SINGLE DOMAIN ANTIBODIES THAT BIND IL-13